These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 20703263)
21. A public health perspective on the control of predictive screening for breast cancer. Cunningham GC Health Matrix Clevel; 1997; 7(1):31-48. PubMed ID: 10167177 [No Abstract] [Full Text] [Related]
22. An outsider's viewpoint: the FDA should regulate clinical pharmacogenetic/genomic tests, but... O'Kane D Clin Pharmacol Ther; 2010 Dec; 88(6):746-8. PubMed ID: 21081942 [No Abstract] [Full Text] [Related]
23. The need for increased oversight of genetic testing: a detailed look at the genetic testing process. Bonnin DC Houst J Health Law Policy; 2003; 4(1):149-80. PubMed ID: 16596751 [No Abstract] [Full Text] [Related]
25. The new drug marketing: a consumer protection perspective. Woodward D Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733 [No Abstract] [Full Text] [Related]
26. FDA resists regulatory role in gene tests. Wadman M Nature; 1996 Nov; 384(6605):101. PubMed ID: 8906776 [No Abstract] [Full Text] [Related]
27. Public health. A case study of personalized medicine. Katsanis SH; Javitt G; Hudson K Science; 2008 Apr; 320(5872):53-4. PubMed ID: 18388277 [No Abstract] [Full Text] [Related]
28. Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era. Evans BJ Clin Pharmacol Ther; 2010 Dec; 88(6):749-51. PubMed ID: 21081943 [TBL] [Abstract][Full Text] [Related]
30. Consumer alert: ethical issues raised by the sale of genetic tests directly to consumers. Wasson K Am J Bioeth; 2008 Jun; 8(6):16-8. PubMed ID: 18726774 [No Abstract] [Full Text] [Related]
31. ASHG Statement* on direct-to-consumer genetic testing in the United States. Hudson K; Javitt G; Burke W; Byers P; Obstet Gynecol; 2007 Dec; 110(6):1392-5. PubMed ID: 18055737 [No Abstract] [Full Text] [Related]
32. Which way for genetic-test regulation? Leave test interpretation to specialists. Beaudet AL Nature; 2010 Aug; 466(7308):816-7. PubMed ID: 20703287 [No Abstract] [Full Text] [Related]
33. Predictive genetic testing: from basic research to clinical practice. Holtzman NA; Murphy PD; Watson MS; Barr PA Science; 1997 Oct; 278(5338):602-5. PubMed ID: 9381169 [No Abstract] [Full Text] [Related]
34. Genetic testing and FDA regulation: overregulation threatens the emergence of genomic medicine. Evans JP; Watson MS JAMA; 2015 Feb; 313(7):669-70. PubMed ID: 25560537 [No Abstract] [Full Text] [Related]
36. Crunch time for multiple-gene tests. Gewin V Nature; 2007 Jan; 445(7126):354-5. PubMed ID: 17251949 [No Abstract] [Full Text] [Related]
37. FDA regulation of genetic testing: institutional reluctance and public guardianship. Huang A Food Drug Law J; 1998; 53(3):555-91. PubMed ID: 10346728 [No Abstract] [Full Text] [Related]
39. Cutting the Gordian helix--regulating genomic testing in the era of precision medicine. Lander ES N Engl J Med; 2015 Mar; 372(13):1185-6. PubMed ID: 25689017 [No Abstract] [Full Text] [Related]
40. Genetic horoscopes: is it all in the genes? Points for regulatory control of direct-to-consumer genetic testing. Patch C; Sequeiros J; Cornel MC Eur J Hum Genet; 2009 Jul; 17(7):857-9. PubMed ID: 19259126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]